These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31303606)

  • 1. Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells.
    Ji J; Fu T; Dong C; Zhu W; Yang J; Kong X; Zhang Z; Bao Y; Zhao R; Ge X; Sha X; Lu Z; Li J; Gu Z
    Aging (Albany NY); 2019 Jul; 11(13):4338-4353. PubMed ID: 31303606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.
    Gu Z; Tan W; Ji J; Feng G; Meng Y; Da Z; Guo G; Xia Y; Zhu X; Shi G; Cheng C
    Aging (Albany NY); 2016 May; 8(5):1102-14. PubMed ID: 27048648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK-STAT signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients.
    Ji J; Wu Y; Meng Y; Zhang L; Feng G; Xia Y; Xue W; Zhao S; Gu Z; Shao X
    Acta Biochim Biophys Sin (Shanghai); 2017 Mar; 49(3):208-215. PubMed ID: 28177455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway.
    Gu Z; Tan W; Feng G; Meng Y; Shen B; Liu H; Cheng C
    Mol Cell Biochem; 2014 Feb; 387(1-2):27-37. PubMed ID: 24130040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High level of reactive oxygen species impaired mesenchymal stem cell migration via overpolymerization of F-actin cytoskeleton in systemic lupus erythematosus.
    Shi D; Li X; Chen H; Che N; Zhou S; Lu Z; Shi S; Sun L
    Pathol Biol (Paris); 2014 Dec; 62(6):382-90. PubMed ID: 25239279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence-Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein-Interferon-β Feedback Loop.
    Gao L; Bird AK; Meednu N; Dauenhauer K; Liesveld J; Anolik J; Looney RJ
    Arthritis Rheumatol; 2017 Aug; 69(8):1623-1635. PubMed ID: 28471483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.
    Cheng T; Ding S; Liu S; Li Y; Sun L
    Theranostics; 2021; 11(2):893-905. PubMed ID: 33391511
    [No Abstract]   [Full Text] [Related]  

  • 8. PTEN/Akt-p27(kip1) Signaling Promote the BM-MSCs Senescence and Apoptosis in SLE Patients.
    Tan W; Gu Z; Shen B; Jiang J; Meng Y; Da Z; Liu H; Tao T; Cheng C
    J Cell Biochem; 2015 Aug; 116(8):1583-94. PubMed ID: 25649549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells-derived Exosomes Ameliorate Lupus by Inducing M2 Macrophage Polarization and Regulatory T Cell Expansion in MRL/lpr Mice.
    Sun W; Yan S; Yang C; Yang J; Wang H; Li C; Zhang L; Zhao L; Zhang J; Cheng M; Li X; Xu D
    Immunol Invest; 2022 Aug; 51(6):1785-1803. PubMed ID: 35332841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Exosomes Derived-miR-146a from Systemic Lupus Erythematosus Patients Regulates Senescence of Mesenchymal Stem Cells.
    Dong C; Zhou Q; Fu T; Zhao R; Yang J; Kong X; Zhang Z; Sun C; Bao Y; Ge X; Zhang Z; Lu Z; Li J; Zheng W; Gu Z; Ji J
    Biomed Res Int; 2019; 2019():6071308. PubMed ID: 31428639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53/p21 Pathway involved in mediating cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients.
    Gu Z; Jiang J; Tan W; Xia Y; Cao H; Meng Y; Da Z; Liu H; Cheng C
    Clin Dev Immunol; 2013; 2013():134243. PubMed ID: 24151513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus].
    Wu Z; Hu M; Zhao Q; Lv F; Zhang J; Zhang W; Wang Y; Sun X; Wang H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Oct; 56(5):860-867. PubMed ID: 39397466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus.
    Tan W; Gu Z; Leng J; Zou X; Chen H; Min F; Zhou W; Zhang L; Li G
    Biomed Pharmacother; 2019 Oct; 118():109313. PubMed ID: 31545233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin enhances the immunomodulatory potential of adipose-derived mesenchymal stem cells through STAT1 in an animal model of lupus.
    Jang SG; Lee J; Hong SM; Kwok SK; Cho ML; Park SH
    Rheumatology (Oxford); 2020 Jun; 59(6):1426-1438. PubMed ID: 31904843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
    Gu Z; Akiyama K; Ma X; Zhang H; Feng X; Yao G; Hou Y; Lu L; Gilkeson GS; Silver RM; Zeng X; Shi S; Sun L
    Lupus; 2010 Nov; 19(13):1502-14. PubMed ID: 20647254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.
    Mai S; Zou L; Tian X; Liao X; Luan Y; Han X; Wei Y; Wu Y; Kuang S; Yang Y; Ma J; Chen Q; Yang J
    Mol Pharm; 2018 May; 15(5):1800-1813. PubMed ID: 29668284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol ester activates human mesenchymal stem cells to inhibit B cells and ameliorate lupus symptoms in MRL.
    Lee HK; Kim HS; Pyo M; Park EJ; Jang S; Jun HW; Lee TY; Kim KS; Bae SC; Kim Y; Hong JT; Yun J; Han SB
    Theranostics; 2020; 10(22):10186-10199. PubMed ID: 32929342
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential regulatory role of the Nrf2/HMGB1/TLR4/NF-κB signaling pathway in lupus nephritis.
    Li SJ; Ruan DD; Wu WZ; Wu M; Wu QY; Wang HL; Ji YY; Zhang YP; Lin XF; Fang ZT; Liao LS; Luo JW; Gao MZ; Wu JB
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):130. PubMed ID: 37872565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
    Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
    Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of HMGB1 in BMSC transplantation for treating MODS in rats.
    Xiu G; Sun J; Li X; Jin H; Zhu Y; Zhou X; Liu P; Pan X; Li J; Ling B
    Cell Tissue Res; 2018 Aug; 373(2):395-406. PubMed ID: 29637307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.